Evidence map›Paper›PMID 37058485›Full record

ArticleBlood advances2023

Commentary on the ASH 2020 guidelines on cognitive screening and intervention in sickle cell disease.

Catherine R Hoyt, Andrew M Heitzer, Steven J Hardy

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Catherine R HoytProgram in Occupational Therapy, Departments of Pediatrics and Neurology, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0002-3398-9439
Andrew M HeitzerDepartment of Psychology, St Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0003-0582-3850
Steven J HardyDivisions of Hematology and Oncology, Children's National Hospital, Washington, DC.ORCID 0000-0002-0491-4980
Children's National · USSt. Jude Children's Research Hospital · USWashington University in St. Louis · US

Funding

Washington University K12 Program in T4 Implementation ResearchK12HL137942 · NHLBI · WASHINGTON UNIVERSITY · PI DAVILA-ROMAN, VICTOR G. · 2017 to 2021
$3.1M
Trajectory of Cognitive Functioning in Youth with Sickle Cell Disease without Cerebral InfarctionK23HL141666 · NHLBI · CHILDREN'S RESEARCH INSTITUTE · PI HARDY, STEVEN JAMES · 2019 to 2023
$698k
Early Identification Of Developmental Delay Among Infants And Toddlers With Sickle Cell DiseaseK23HL161328 · NHLBI · WASHINGTON UNIVERSITY · PI Catherine Rose Hoyt · 2023 to 2026
$554k
NHLBI NIH HHS K12 HL137942NHLBI NIH HHS K23 HL141666NHLBI NIH HHS K23 HL161328
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anemia, Sickle CellCognitionHumans

Identifiers

PMID37058485
PMCPMC10365932
OpenAlexW4365479121

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.